topotecan has been researched along with abt-199 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benes, CH; Cai, J; Casey, C; Coon, C; Crowther, GS; D'Aulerio, A; Dalton, KM; Dozmorov, M; Faber, AC; Greninger, P; Hu, B; Jacob, S; Khan, QA; Krytska, K; Kurupi, R; Lochmann, TL; Mossé, YP; Sano, R; Souers, AJ | 1 |
| Carta, R; Cefalo, MG; D'Andrea, ML; De Ioris, MA; Del Baldo, G; Del Bufalo, F; Fabozzi, F; Garganese, MC; Giovannoni, I; Greco, AM; Locatelli, F; Mastronuzzi, A; Stracuzzi, A; Tangari, F; Villani, MF | 1 |
2 other study(ies) available for topotecan and abt-199
| Article | Year |
|---|---|
Venetoclax-based Rational Combinations are Effective in Models of
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Cyclophosphamide; Female; Gene Amplification; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred NOD; Mice, SCID; N-Myc Proto-Oncogene Protein; Neuroblastoma; Sulfonamides; Topotecan; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Child; Chronic Disease; Cyclophosphamide; Humans; Mice; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroblastoma; Proto-Oncogene Proteins c-bcl-2; Topotecan | 2023 |